Neurorehabilitation Devices - Comprehensive Study by Type (Nuro-robotic device, Non-invasive stimulator, Wearable devices, Brain-computer interface, Others), Application (Parkinson's disease, Bran trauma injury, Spinal cord injury, Stroke, Schizophrenia, Cerebral palsy, Others), End users (Hospitals/clinics, Research institution, Cognitive care centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Ecommerce) Players and Region - Global Market Outlook to 2027

Neurorehabilitation Devices - Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Neurorehabilitation Devices - Market Scope
Neurological rehabilitation is a doctor-supervised program designed for people with diseases, injuries, or disorders of the nervous system. Neurological rehab can often improve function, reduce symptoms, and improve the well-being of the patient. Neurorehabilitation Device uses this technique in the field of physiotherapy. Regardless of the cause of the disability, most neurological rehabilitation devices are intended to facilitate the learning or relearning of motor skills. Development in neuroimaging techniques has greatly enhanced the scope and outcome of neurorehabilitation. Neurorehabilitation devices include non-invasive brain stimulators, neurorobotics systems, brain-computer interfaces, and wearable devices. Increased prevalence and incidence of neurological disorders are key drivers of growth and demand for Neurorehabilitation equipment.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledNeuroPace, Inc. (United States), Mindmaze (Switzerland), Neuros Medical (United States), Flow Neuroscience (Sweden), NEURALINK (United States), Hocona AG (Switzerland), BrainCo, Inc. (United States), Medtronic (Ireland), Synchron (United States), Halo Neuroscience (United States) and usMIMA. (United States)
CAGR%


Competition among existing players is due to the stiff market share occupied by leading players. The industry leader is engaged in offering innovative and superior-quality products to cater to the ever-growing demand for neurorehabilitation devices. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Neurorehabilitation Devices - market throughout the predicted period.

NeuroPace, Inc. (United States), Mindmaze (Switzerland), Neuros Medical (United States), Flow Neuroscience (Sweden), NEURALINK (United States), Hocona AG (Switzerland), BrainCo, Inc. (United States), Medtronic (Ireland), Synchron (United States), Halo Neuroscience (United States) and usMIMA. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Rehabtronics Inc (Canada), Thync Global, Inc. (United States), Kernel (United States), Rehab Robotics (Hong Kong), Tyromotion GmbH (AUSTRIA) and NextStep Robotics (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Neurorehabilitation Devices - market by Type , by Application (Parkinson's disease, Bran trauma injury, Spinal cord injury, Stroke, Schizophrenia, Cerebral palsy and Others) and Region with country level break-up.

On the basis of geography, the market of Neurorehabilitation Devices - has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
In November 2018, Neurocognitive rehabilitation company MindMaze acquires Neuro Motor Innovations Corporation, Itís an artificial intelligence-powered video game that stroke patients control through controlled motor functions. The offering is designed to treat neurological diseases and injuries both acute and chronic.
In August 2021, NeuroPace launches epilepsy platform to personalize seizure care, California-based NeuroPace launched a new portal, called the nSight Platform. It's able to gather information about a patient's seizures and health progress outside of a hospital.


Influencing Trend:
Rising cases of neurological disorders and the availability of numerous approved devices

Market Growth Drivers:
Neurorehabilitation devices also have a real potential to save patients money

Challenges:
The government pays less attention to rehab services

Restraints:
Lack of skilled specialists in the Neurorehabilitation devices markets

Opportunities:
Growing demand of Functional electrical stimulation and Virtual reality rehabilitation having in wearable technology

Key Target Audience
Manufacturers, suppliers, Governments regulatory, Industry Experts, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Nuro-robotic device
  • Non-invasive stimulator
  • Wearable devices
  • Brain-computer interface
  • Others
By Application
  • Parkinson's disease
  • Bran trauma injury
  • Spinal cord injury
  • Stroke
  • Schizophrenia
  • Cerebral palsy
  • Others
By End users
  • Hospitals/clinics
  • Research institution
  • Cognitive care centers
  • Others

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacies
  • Ecommerce

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Neurorehabilitation devices also have a real potential to save patients money
    • 3.3. Market Challenges
      • 3.3.1. The government pays less attention to rehab services
    • 3.4. Market Trends
      • 3.4.1. Rising cases of neurological disorders and the availability of numerous approved devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurorehabilitation Devices -, by Type, Application, End users, Distribution Channel and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Neurorehabilitation Devices - (Value)
      • 5.2.1. Global Neurorehabilitation Devices - by: Type (Value)
        • 5.2.1.1. Nuro-robotic device
        • 5.2.1.2. Non-invasive stimulator
        • 5.2.1.3. Wearable devices
        • 5.2.1.4. Brain-computer interface
        • 5.2.1.5. Others
      • 5.2.2. Global Neurorehabilitation Devices - by: Application (Value)
        • 5.2.2.1. Parkinson's disease
        • 5.2.2.2. Bran trauma injury
        • 5.2.2.3. Spinal cord injury
        • 5.2.2.4. Stroke
        • 5.2.2.5. Schizophrenia
        • 5.2.2.6. Cerebral palsy
        • 5.2.2.7. Others
      • 5.2.3. Global Neurorehabilitation Devices - by: End users (Value)
        • 5.2.3.1. Hospitals/clinics
        • 5.2.3.2. Research institution
        • 5.2.3.3. Cognitive care centers
        • 5.2.3.4. Others
      • 5.2.4. Global Neurorehabilitation Devices - by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacy
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Ecommerce
      • 5.2.5. Global Neurorehabilitation Devices - Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Neurorehabilitation Devices - (Volume)
      • 5.3.1. Global Neurorehabilitation Devices - by: Type (Volume)
        • 5.3.1.1. Nuro-robotic device
        • 5.3.1.2. Non-invasive stimulator
        • 5.3.1.3. Wearable devices
        • 5.3.1.4. Brain-computer interface
        • 5.3.1.5. Others
      • 5.3.2. Global Neurorehabilitation Devices - by: Application (Volume)
        • 5.3.2.1. Parkinson's disease
        • 5.3.2.2. Bran trauma injury
        • 5.3.2.3. Spinal cord injury
        • 5.3.2.4. Stroke
        • 5.3.2.5. Schizophrenia
        • 5.3.2.6. Cerebral palsy
        • 5.3.2.7. Others
      • 5.3.3. Global Neurorehabilitation Devices - by: End users (Volume)
        • 5.3.3.1. Hospitals/clinics
        • 5.3.3.2. Research institution
        • 5.3.3.3. Cognitive care centers
        • 5.3.3.4. Others
      • 5.3.4. Global Neurorehabilitation Devices - by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacy
        • 5.3.4.2. Retail Pharmacies
        • 5.3.4.3. Ecommerce
      • 5.3.5. Global Neurorehabilitation Devices - Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Neurorehabilitation Devices - (Price)
      • 5.4.1. Global Neurorehabilitation Devices - by: Type (Price)
  • 6. Neurorehabilitation Devices -: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. NeuroPace, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mindmaze (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Neuros Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Flow Neuroscience (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NEURALINK (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hocona AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BrainCo, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Synchron (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Halo Neuroscience (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. UsMIMA. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Neurorehabilitation Devices - Sale, by Type, Application, End users, Distribution Channel and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Neurorehabilitation Devices - (Value)
      • 7.2.1. Global Neurorehabilitation Devices - by: Type (Value)
        • 7.2.1.1. Nuro-robotic device
        • 7.2.1.2. Non-invasive stimulator
        • 7.2.1.3. Wearable devices
        • 7.2.1.4. Brain-computer interface
        • 7.2.1.5. Others
      • 7.2.2. Global Neurorehabilitation Devices - by: Application (Value)
        • 7.2.2.1. Parkinson's disease
        • 7.2.2.2. Bran trauma injury
        • 7.2.2.3. Spinal cord injury
        • 7.2.2.4. Stroke
        • 7.2.2.5. Schizophrenia
        • 7.2.2.6. Cerebral palsy
        • 7.2.2.7. Others
      • 7.2.3. Global Neurorehabilitation Devices - by: End users (Value)
        • 7.2.3.1. Hospitals/clinics
        • 7.2.3.2. Research institution
        • 7.2.3.3. Cognitive care centers
        • 7.2.3.4. Others
      • 7.2.4. Global Neurorehabilitation Devices - by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacy
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Ecommerce
      • 7.2.5. Global Neurorehabilitation Devices - Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Neurorehabilitation Devices - (Volume)
      • 7.3.1. Global Neurorehabilitation Devices - by: Type (Volume)
        • 7.3.1.1. Nuro-robotic device
        • 7.3.1.2. Non-invasive stimulator
        • 7.3.1.3. Wearable devices
        • 7.3.1.4. Brain-computer interface
        • 7.3.1.5. Others
      • 7.3.2. Global Neurorehabilitation Devices - by: Application (Volume)
        • 7.3.2.1. Parkinson's disease
        • 7.3.2.2. Bran trauma injury
        • 7.3.2.3. Spinal cord injury
        • 7.3.2.4. Stroke
        • 7.3.2.5. Schizophrenia
        • 7.3.2.6. Cerebral palsy
        • 7.3.2.7. Others
      • 7.3.3. Global Neurorehabilitation Devices - by: End users (Volume)
        • 7.3.3.1. Hospitals/clinics
        • 7.3.3.2. Research institution
        • 7.3.3.3. Cognitive care centers
        • 7.3.3.4. Others
      • 7.3.4. Global Neurorehabilitation Devices - by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacy
        • 7.3.4.2. Retail Pharmacies
        • 7.3.4.3. Ecommerce
      • 7.3.5. Global Neurorehabilitation Devices - Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Neurorehabilitation Devices - (Price)
      • 7.4.1. Global Neurorehabilitation Devices - by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurorehabilitation Devices -: by Type(USD Million)
  • Table 2. Neurorehabilitation Devices - Nuro-robotic device , by Region USD Million (2016-2021)
  • Table 3. Neurorehabilitation Devices - Non-invasive stimulator , by Region USD Million (2016-2021)
  • Table 4. Neurorehabilitation Devices - Wearable devices , by Region USD Million (2016-2021)
  • Table 5. Neurorehabilitation Devices - Brain-computer interface , by Region USD Million (2016-2021)
  • Table 6. Neurorehabilitation Devices - Others , by Region USD Million (2016-2021)
  • Table 7. Neurorehabilitation Devices -: by Application(USD Million)
  • Table 8. Neurorehabilitation Devices - Parkinson's disease , by Region USD Million (2016-2021)
  • Table 9. Neurorehabilitation Devices - Bran trauma injury , by Region USD Million (2016-2021)
  • Table 10. Neurorehabilitation Devices - Spinal cord injury , by Region USD Million (2016-2021)
  • Table 11. Neurorehabilitation Devices - Stroke , by Region USD Million (2016-2021)
  • Table 12. Neurorehabilitation Devices - Schizophrenia , by Region USD Million (2016-2021)
  • Table 13. Neurorehabilitation Devices - Cerebral palsy , by Region USD Million (2016-2021)
  • Table 14. Neurorehabilitation Devices - Others , by Region USD Million (2016-2021)
  • Table 15. Neurorehabilitation Devices -: by End users(USD Million)
  • Table 16. Neurorehabilitation Devices - Hospitals/clinics , by Region USD Million (2016-2021)
  • Table 17. Neurorehabilitation Devices - Research institution , by Region USD Million (2016-2021)
  • Table 18. Neurorehabilitation Devices - Cognitive care centers , by Region USD Million (2016-2021)
  • Table 19. Neurorehabilitation Devices - Others , by Region USD Million (2016-2021)
  • Table 20. Neurorehabilitation Devices -: by Distribution Channel(USD Million)
  • Table 21. Neurorehabilitation Devices - Hospital Pharmacy , by Region USD Million (2016-2021)
  • Table 22. Neurorehabilitation Devices - Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 23. Neurorehabilitation Devices - Ecommerce , by Region USD Million (2016-2021)
  • Table 24. South America Neurorehabilitation Devices -, by Country USD Million (2016-2021)
  • Table 25. South America Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 26. South America Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 27. South America Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 28. South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 29. Brazil Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 30. Brazil Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 31. Brazil Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 32. Brazil Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 33. Argentina Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 34. Argentina Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 35. Argentina Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 36. Argentina Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 37. Rest of South America Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 38. Rest of South America Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 39. Rest of South America Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 40. Rest of South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 41. Asia Pacific Neurorehabilitation Devices -, by Country USD Million (2016-2021)
  • Table 42. Asia Pacific Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 43. Asia Pacific Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 44. Asia Pacific Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 45. Asia Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 46. China Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 47. China Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 48. China Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 49. China Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 50. Japan Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 51. Japan Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 52. Japan Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 53. Japan Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 54. India Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 55. India Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 56. India Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 57. India Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 58. South Korea Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 59. South Korea Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 60. South Korea Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 61. South Korea Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 62. Taiwan Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 63. Taiwan Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 64. Taiwan Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 65. Taiwan Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 66. Australia Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 67. Australia Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 68. Australia Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 69. Australia Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 72. Rest of Asia-Pacific Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 73. Rest of Asia-Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 74. Europe Neurorehabilitation Devices -, by Country USD Million (2016-2021)
  • Table 75. Europe Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 76. Europe Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 77. Europe Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 78. Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 79. Germany Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 80. Germany Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 81. Germany Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 82. Germany Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 83. France Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 84. France Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 85. France Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 86. France Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 87. Italy Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 88. Italy Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 89. Italy Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 90. Italy Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 91. United Kingdom Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 92. United Kingdom Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 93. United Kingdom Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 94. United Kingdom Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 95. Netherlands Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 96. Netherlands Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 97. Netherlands Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 98. Netherlands Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 99. Rest of Europe Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 100. Rest of Europe Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 101. Rest of Europe Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 102. Rest of Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 103. MEA Neurorehabilitation Devices -, by Country USD Million (2016-2021)
  • Table 104. MEA Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 105. MEA Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 106. MEA Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 107. MEA Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 108. Middle East Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 109. Middle East Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 110. Middle East Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 111. Middle East Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 112. Africa Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 113. Africa Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 114. Africa Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 115. Africa Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 116. North America Neurorehabilitation Devices -, by Country USD Million (2016-2021)
  • Table 117. North America Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 118. North America Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 119. North America Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 120. North America Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 121. United States Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 122. United States Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 123. United States Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 124. United States Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 125. Canada Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 126. Canada Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 127. Canada Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 128. Canada Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 129. Mexico Neurorehabilitation Devices -, by Type USD Million (2016-2021)
  • Table 130. Mexico Neurorehabilitation Devices -, by Application USD Million (2016-2021)
  • Table 131. Mexico Neurorehabilitation Devices -, by End users USD Million (2016-2021)
  • Table 132. Mexico Neurorehabilitation Devices -, by Distribution Channel USD Million (2016-2021)
  • Table 133. Neurorehabilitation Devices - Sales: by Type(K Units)
  • Table 134. Neurorehabilitation Devices - Sales Nuro-robotic device , by Region K Units (2016-2021)
  • Table 135. Neurorehabilitation Devices - Sales Non-invasive stimulator , by Region K Units (2016-2021)
  • Table 136. Neurorehabilitation Devices - Sales Wearable devices , by Region K Units (2016-2021)
  • Table 137. Neurorehabilitation Devices - Sales Brain-computer interface , by Region K Units (2016-2021)
  • Table 138. Neurorehabilitation Devices - Sales Others , by Region K Units (2016-2021)
  • Table 139. Neurorehabilitation Devices - Sales: by Application(K Units)
  • Table 140. Neurorehabilitation Devices - Sales Parkinson's disease , by Region K Units (2016-2021)
  • Table 141. Neurorehabilitation Devices - Sales Bran trauma injury , by Region K Units (2016-2021)
  • Table 142. Neurorehabilitation Devices - Sales Spinal cord injury , by Region K Units (2016-2021)
  • Table 143. Neurorehabilitation Devices - Sales Stroke , by Region K Units (2016-2021)
  • Table 144. Neurorehabilitation Devices - Sales Schizophrenia , by Region K Units (2016-2021)
  • Table 145. Neurorehabilitation Devices - Sales Cerebral palsy , by Region K Units (2016-2021)
  • Table 146. Neurorehabilitation Devices - Sales Others , by Region K Units (2016-2021)
  • Table 147. Neurorehabilitation Devices - Sales: by End users(K Units)
  • Table 148. Neurorehabilitation Devices - Sales Hospitals/clinics , by Region K Units (2016-2021)
  • Table 149. Neurorehabilitation Devices - Sales Research institution , by Region K Units (2016-2021)
  • Table 150. Neurorehabilitation Devices - Sales Cognitive care centers , by Region K Units (2016-2021)
  • Table 151. Neurorehabilitation Devices - Sales Others , by Region K Units (2016-2021)
  • Table 152. Neurorehabilitation Devices - Sales: by Distribution Channel(K Units)
  • Table 153. Neurorehabilitation Devices - Sales Hospital Pharmacy , by Region K Units (2016-2021)
  • Table 154. Neurorehabilitation Devices - Sales Retail Pharmacies , by Region K Units (2016-2021)
  • Table 155. Neurorehabilitation Devices - Sales Ecommerce , by Region K Units (2016-2021)
  • Table 156. South America Neurorehabilitation Devices - Sales, by Country K Units (2016-2021)
  • Table 157. South America Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 158. South America Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 159. South America Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 160. South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 161. Brazil Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 162. Brazil Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 163. Brazil Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 164. Brazil Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 165. Argentina Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 166. Argentina Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 167. Argentina Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 168. Argentina Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 169. Rest of South America Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 170. Rest of South America Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 171. Rest of South America Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 172. Rest of South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 173. Asia Pacific Neurorehabilitation Devices - Sales, by Country K Units (2016-2021)
  • Table 174. Asia Pacific Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 175. Asia Pacific Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 176. Asia Pacific Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 177. Asia Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 178. China Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 179. China Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 180. China Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 181. China Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 182. Japan Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 183. Japan Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 184. Japan Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 185. Japan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 186. India Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 187. India Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 188. India Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 189. India Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 190. South Korea Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 191. South Korea Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 192. South Korea Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 193. South Korea Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 194. Taiwan Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 195. Taiwan Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 196. Taiwan Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 197. Taiwan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 198. Australia Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 199. Australia Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 200. Australia Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 201. Australia Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 202. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 203. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 204. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 205. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 206. Europe Neurorehabilitation Devices - Sales, by Country K Units (2016-2021)
  • Table 207. Europe Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 208. Europe Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 209. Europe Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 210. Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 211. Germany Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 212. Germany Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 213. Germany Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 214. Germany Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 215. France Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 216. France Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 217. France Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 218. France Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 219. Italy Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 220. Italy Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 221. Italy Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 222. Italy Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 223. United Kingdom Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 224. United Kingdom Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 225. United Kingdom Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 226. United Kingdom Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 227. Netherlands Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 228. Netherlands Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 229. Netherlands Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 230. Netherlands Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 231. Rest of Europe Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 232. Rest of Europe Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 233. Rest of Europe Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 234. Rest of Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 235. MEA Neurorehabilitation Devices - Sales, by Country K Units (2016-2021)
  • Table 236. MEA Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 237. MEA Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 238. MEA Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 239. MEA Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 240. Middle East Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 241. Middle East Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 242. Middle East Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 243. Middle East Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 244. Africa Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 245. Africa Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 246. Africa Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 247. Africa Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 248. North America Neurorehabilitation Devices - Sales, by Country K Units (2016-2021)
  • Table 249. North America Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 250. North America Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 251. North America Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 252. North America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 253. United States Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 254. United States Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 255. United States Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 256. United States Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 257. Canada Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 258. Canada Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 259. Canada Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 260. Canada Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 261. Mexico Neurorehabilitation Devices - Sales, by Type K Units (2016-2021)
  • Table 262. Mexico Neurorehabilitation Devices - Sales, by Application K Units (2016-2021)
  • Table 263. Mexico Neurorehabilitation Devices - Sales, by End users K Units (2016-2021)
  • Table 264. Mexico Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2016-2021)
  • Table 265. Neurorehabilitation Devices -: by Type(USD/Units)
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Company Basic Information, Sales Area and Its Competitors
  • Table 277. Neurorehabilitation Devices -: by Type(USD Million)
  • Table 278. Neurorehabilitation Devices - Nuro-robotic device , by Region USD Million (2022-2027)
  • Table 279. Neurorehabilitation Devices - Non-invasive stimulator , by Region USD Million (2022-2027)
  • Table 280. Neurorehabilitation Devices - Wearable devices , by Region USD Million (2022-2027)
  • Table 281. Neurorehabilitation Devices - Brain-computer interface , by Region USD Million (2022-2027)
  • Table 282. Neurorehabilitation Devices - Others , by Region USD Million (2022-2027)
  • Table 283. Neurorehabilitation Devices -: by Application(USD Million)
  • Table 284. Neurorehabilitation Devices - Parkinson's disease , by Region USD Million (2022-2027)
  • Table 285. Neurorehabilitation Devices - Bran trauma injury , by Region USD Million (2022-2027)
  • Table 286. Neurorehabilitation Devices - Spinal cord injury , by Region USD Million (2022-2027)
  • Table 287. Neurorehabilitation Devices - Stroke , by Region USD Million (2022-2027)
  • Table 288. Neurorehabilitation Devices - Schizophrenia , by Region USD Million (2022-2027)
  • Table 289. Neurorehabilitation Devices - Cerebral palsy , by Region USD Million (2022-2027)
  • Table 290. Neurorehabilitation Devices - Others , by Region USD Million (2022-2027)
  • Table 291. Neurorehabilitation Devices -: by End users(USD Million)
  • Table 292. Neurorehabilitation Devices - Hospitals/clinics , by Region USD Million (2022-2027)
  • Table 293. Neurorehabilitation Devices - Research institution , by Region USD Million (2022-2027)
  • Table 294. Neurorehabilitation Devices - Cognitive care centers , by Region USD Million (2022-2027)
  • Table 295. Neurorehabilitation Devices - Others , by Region USD Million (2022-2027)
  • Table 296. Neurorehabilitation Devices -: by Distribution Channel(USD Million)
  • Table 297. Neurorehabilitation Devices - Hospital Pharmacy , by Region USD Million (2022-2027)
  • Table 298. Neurorehabilitation Devices - Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 299. Neurorehabilitation Devices - Ecommerce , by Region USD Million (2022-2027)
  • Table 300. South America Neurorehabilitation Devices -, by Country USD Million (2022-2027)
  • Table 301. South America Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 302. South America Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 303. South America Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 304. South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 305. Brazil Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 306. Brazil Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 307. Brazil Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 308. Brazil Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 309. Argentina Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 310. Argentina Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 311. Argentina Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 312. Argentina Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 313. Rest of South America Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 314. Rest of South America Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 315. Rest of South America Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 316. Rest of South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 317. Asia Pacific Neurorehabilitation Devices -, by Country USD Million (2022-2027)
  • Table 318. Asia Pacific Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 319. Asia Pacific Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 320. Asia Pacific Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 321. Asia Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 322. China Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 323. China Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 324. China Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 325. China Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 326. Japan Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 327. Japan Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 328. Japan Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 329. Japan Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 330. India Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 331. India Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 332. India Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 333. India Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 334. South Korea Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 335. South Korea Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 336. South Korea Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 337. South Korea Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 338. Taiwan Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 339. Taiwan Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 340. Taiwan Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 341. Taiwan Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 342. Australia Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 343. Australia Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 344. Australia Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 345. Australia Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 346. Rest of Asia-Pacific Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 347. Rest of Asia-Pacific Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 348. Rest of Asia-Pacific Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 349. Rest of Asia-Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 350. Europe Neurorehabilitation Devices -, by Country USD Million (2022-2027)
  • Table 351. Europe Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 352. Europe Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 353. Europe Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 354. Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 355. Germany Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 356. Germany Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 357. Germany Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 358. Germany Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 359. France Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 360. France Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 361. France Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 362. France Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 363. Italy Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 364. Italy Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 365. Italy Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 366. Italy Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 367. United Kingdom Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 368. United Kingdom Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 369. United Kingdom Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 370. United Kingdom Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 371. Netherlands Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 372. Netherlands Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 373. Netherlands Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 374. Netherlands Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 375. Rest of Europe Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 376. Rest of Europe Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 377. Rest of Europe Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 378. Rest of Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 379. MEA Neurorehabilitation Devices -, by Country USD Million (2022-2027)
  • Table 380. MEA Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 381. MEA Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 382. MEA Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 383. MEA Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 384. Middle East Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 385. Middle East Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 386. Middle East Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 387. Middle East Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 388. Africa Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 389. Africa Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 390. Africa Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 391. Africa Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 392. North America Neurorehabilitation Devices -, by Country USD Million (2022-2027)
  • Table 393. North America Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 394. North America Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 395. North America Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 396. North America Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 397. United States Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 398. United States Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 399. United States Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 400. United States Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 401. Canada Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 402. Canada Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 403. Canada Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 404. Canada Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 405. Mexico Neurorehabilitation Devices -, by Type USD Million (2022-2027)
  • Table 406. Mexico Neurorehabilitation Devices -, by Application USD Million (2022-2027)
  • Table 407. Mexico Neurorehabilitation Devices -, by End users USD Million (2022-2027)
  • Table 408. Mexico Neurorehabilitation Devices -, by Distribution Channel USD Million (2022-2027)
  • Table 409. Neurorehabilitation Devices - Sales: by Type(K Units)
  • Table 410. Neurorehabilitation Devices - Sales Nuro-robotic device , by Region K Units (2022-2027)
  • Table 411. Neurorehabilitation Devices - Sales Non-invasive stimulator , by Region K Units (2022-2027)
  • Table 412. Neurorehabilitation Devices - Sales Wearable devices , by Region K Units (2022-2027)
  • Table 413. Neurorehabilitation Devices - Sales Brain-computer interface , by Region K Units (2022-2027)
  • Table 414. Neurorehabilitation Devices - Sales Others , by Region K Units (2022-2027)
  • Table 415. Neurorehabilitation Devices - Sales: by Application(K Units)
  • Table 416. Neurorehabilitation Devices - Sales Parkinson's disease , by Region K Units (2022-2027)
  • Table 417. Neurorehabilitation Devices - Sales Bran trauma injury , by Region K Units (2022-2027)
  • Table 418. Neurorehabilitation Devices - Sales Spinal cord injury , by Region K Units (2022-2027)
  • Table 419. Neurorehabilitation Devices - Sales Stroke , by Region K Units (2022-2027)
  • Table 420. Neurorehabilitation Devices - Sales Schizophrenia , by Region K Units (2022-2027)
  • Table 421. Neurorehabilitation Devices - Sales Cerebral palsy , by Region K Units (2022-2027)
  • Table 422. Neurorehabilitation Devices - Sales Others , by Region K Units (2022-2027)
  • Table 423. Neurorehabilitation Devices - Sales: by End users(K Units)
  • Table 424. Neurorehabilitation Devices - Sales Hospitals/clinics , by Region K Units (2022-2027)
  • Table 425. Neurorehabilitation Devices - Sales Research institution , by Region K Units (2022-2027)
  • Table 426. Neurorehabilitation Devices - Sales Cognitive care centers , by Region K Units (2022-2027)
  • Table 427. Neurorehabilitation Devices - Sales Others , by Region K Units (2022-2027)
  • Table 428. Neurorehabilitation Devices - Sales: by Distribution Channel(K Units)
  • Table 429. Neurorehabilitation Devices - Sales Hospital Pharmacy , by Region K Units (2022-2027)
  • Table 430. Neurorehabilitation Devices - Sales Retail Pharmacies , by Region K Units (2022-2027)
  • Table 431. Neurorehabilitation Devices - Sales Ecommerce , by Region K Units (2022-2027)
  • Table 432. South America Neurorehabilitation Devices - Sales, by Country K Units (2022-2027)
  • Table 433. South America Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 434. South America Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 435. South America Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 436. South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 437. Brazil Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 438. Brazil Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 439. Brazil Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 440. Brazil Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 441. Argentina Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 442. Argentina Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 443. Argentina Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 444. Argentina Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 445. Rest of South America Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 446. Rest of South America Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 447. Rest of South America Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 448. Rest of South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 449. Asia Pacific Neurorehabilitation Devices - Sales, by Country K Units (2022-2027)
  • Table 450. Asia Pacific Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 451. Asia Pacific Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 452. Asia Pacific Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 453. Asia Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 454. China Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 455. China Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 456. China Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 457. China Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 458. Japan Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 459. Japan Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 460. Japan Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 461. Japan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 462. India Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 463. India Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 464. India Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 465. India Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 466. South Korea Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 467. South Korea Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 468. South Korea Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 469. South Korea Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 470. Taiwan Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 471. Taiwan Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 472. Taiwan Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 473. Taiwan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 474. Australia Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 475. Australia Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 476. Australia Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 477. Australia Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 478. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 479. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 480. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 481. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 482. Europe Neurorehabilitation Devices - Sales, by Country K Units (2022-2027)
  • Table 483. Europe Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 484. Europe Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 485. Europe Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 486. Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 487. Germany Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 488. Germany Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 489. Germany Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 490. Germany Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 491. France Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 492. France Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 493. France Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 494. France Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 495. Italy Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 496. Italy Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 497. Italy Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 498. Italy Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 499. United Kingdom Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 500. United Kingdom Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 501. United Kingdom Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 502. United Kingdom Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 503. Netherlands Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 504. Netherlands Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 505. Netherlands Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 506. Netherlands Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 507. Rest of Europe Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 508. Rest of Europe Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 509. Rest of Europe Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 510. Rest of Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 511. MEA Neurorehabilitation Devices - Sales, by Country K Units (2022-2027)
  • Table 512. MEA Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 513. MEA Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 514. MEA Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 515. MEA Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 516. Middle East Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 517. Middle East Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 518. Middle East Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 519. Middle East Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 520. Africa Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 521. Africa Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 522. Africa Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 523. Africa Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 524. North America Neurorehabilitation Devices - Sales, by Country K Units (2022-2027)
  • Table 525. North America Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 526. North America Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 527. North America Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 528. North America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 529. United States Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 530. United States Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 531. United States Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 532. United States Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 533. Canada Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 534. Canada Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 535. Canada Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 536. Canada Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 537. Mexico Neurorehabilitation Devices - Sales, by Type K Units (2022-2027)
  • Table 538. Mexico Neurorehabilitation Devices - Sales, by Application K Units (2022-2027)
  • Table 539. Mexico Neurorehabilitation Devices - Sales, by End users K Units (2022-2027)
  • Table 540. Mexico Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2022-2027)
  • Table 541. Neurorehabilitation Devices -: by Type(USD/Units)
  • Table 542. Research Programs/Design for This Report
  • Table 543. Key Data Information from Secondary Sources
  • Table 544. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurorehabilitation Devices -: by Type USD Million (2016-2021)
  • Figure 5. Global Neurorehabilitation Devices -: by Application USD Million (2016-2021)
  • Figure 6. Global Neurorehabilitation Devices -: by End users USD Million (2016-2021)
  • Figure 7. Global Neurorehabilitation Devices -: by Distribution Channel USD Million (2016-2021)
  • Figure 8. South America Neurorehabilitation Devices - Share (%), by Country
  • Figure 9. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
  • Figure 10. Europe Neurorehabilitation Devices - Share (%), by Country
  • Figure 11. MEA Neurorehabilitation Devices - Share (%), by Country
  • Figure 12. North America Neurorehabilitation Devices - Share (%), by Country
  • Figure 13. Global Neurorehabilitation Devices -: by Type K Units (2016-2021)
  • Figure 14. Global Neurorehabilitation Devices -: by Application K Units (2016-2021)
  • Figure 15. Global Neurorehabilitation Devices -: by End users K Units (2016-2021)
  • Figure 16. Global Neurorehabilitation Devices -: by Distribution Channel K Units (2016-2021)
  • Figure 17. South America Neurorehabilitation Devices - Share (%), by Country
  • Figure 18. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
  • Figure 19. Europe Neurorehabilitation Devices - Share (%), by Country
  • Figure 20. MEA Neurorehabilitation Devices - Share (%), by Country
  • Figure 21. North America Neurorehabilitation Devices - Share (%), by Country
  • Figure 22. Global Neurorehabilitation Devices -: by Type USD/Units (2016-2021)
  • Figure 23. Global Neurorehabilitation Devices - share by Players 2021 (%)
  • Figure 24. Global Neurorehabilitation Devices - share by Players (Top 3) 2021(%)
  • Figure 25. Global Neurorehabilitation Devices - share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. NeuroPace, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. NeuroPace, Inc. (United States) Revenue: by Geography 2021
  • Figure 29. Mindmaze (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Mindmaze (Switzerland) Revenue: by Geography 2021
  • Figure 31. Neuros Medical (United States) Revenue, Net Income and Gross profit
  • Figure 32. Neuros Medical (United States) Revenue: by Geography 2021
  • Figure 33. Flow Neuroscience (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Flow Neuroscience (Sweden) Revenue: by Geography 2021
  • Figure 35. NEURALINK (United States) Revenue, Net Income and Gross profit
  • Figure 36. NEURALINK (United States) Revenue: by Geography 2021
  • Figure 37. Hocona AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Hocona AG (Switzerland) Revenue: by Geography 2021
  • Figure 39. BrainCo, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. BrainCo, Inc. (United States) Revenue: by Geography 2021
  • Figure 41. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 43. Synchron (United States) Revenue, Net Income and Gross profit
  • Figure 44. Synchron (United States) Revenue: by Geography 2021
  • Figure 45. Halo Neuroscience (United States) Revenue, Net Income and Gross profit
  • Figure 46. Halo Neuroscience (United States) Revenue: by Geography 2021
  • Figure 47. UsMIMA. (United States) Revenue, Net Income and Gross profit
  • Figure 48. UsMIMA. (United States) Revenue: by Geography 2021
  • Figure 49. Global Neurorehabilitation Devices -: by Type USD Million (2022-2027)
  • Figure 50. Global Neurorehabilitation Devices -: by Application USD Million (2022-2027)
  • Figure 51. Global Neurorehabilitation Devices -: by End users USD Million (2022-2027)
  • Figure 52. Global Neurorehabilitation Devices -: by Distribution Channel USD Million (2022-2027)
  • Figure 53. South America Neurorehabilitation Devices - Share (%), by Country
  • Figure 54. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
  • Figure 55. Europe Neurorehabilitation Devices - Share (%), by Country
  • Figure 56. MEA Neurorehabilitation Devices - Share (%), by Country
  • Figure 57. North America Neurorehabilitation Devices - Share (%), by Country
  • Figure 58. Global Neurorehabilitation Devices -: by Type K Units (2022-2027)
  • Figure 59. Global Neurorehabilitation Devices -: by Application K Units (2022-2027)
  • Figure 60. Global Neurorehabilitation Devices -: by End users K Units (2022-2027)
  • Figure 61. Global Neurorehabilitation Devices -: by Distribution Channel K Units (2022-2027)
  • Figure 62. South America Neurorehabilitation Devices - Share (%), by Country
  • Figure 63. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
  • Figure 64. Europe Neurorehabilitation Devices - Share (%), by Country
  • Figure 65. MEA Neurorehabilitation Devices - Share (%), by Country
  • Figure 66. North America Neurorehabilitation Devices - Share (%), by Country
  • Figure 67. Global Neurorehabilitation Devices -: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • NeuroPace, Inc. (United States)
  • Mindmaze (Switzerland)
  • Neuros Medical (United States)
  • Flow Neuroscience (Sweden)
  • NEURALINK (United States)
  • Hocona AG (Switzerland)
  • BrainCo, Inc. (United States)
  • Medtronic (Ireland)
  • Synchron (United States)
  • Halo Neuroscience (United States)
  • usMIMA. (United States)
Additional players considered in the study are as follows:
Rehabtronics Inc (Canada) , Thync Global, Inc. (United States) , Kernel (United States) , Rehab Robotics (Hong Kong) , Tyromotion GmbH (AUSTRIA) , NextStep Robotics (United States)
Select User Access Type

Key Highlights of Report


Jan 2023 217 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Neurorehabilitation Devices - Market are by type [Nuro-robotic device, Non-invasive stimulator, Wearable devices, Brain-computer interface and Others], by end use application [Parkinson's disease, Bran trauma injury, Spinal cord injury, Stroke, Schizophrenia, Cerebral palsy and Others].
The Neurorehabilitation Devices - Market is gaining popularity and expected to see strong valuation by 2027.
  • Neurorehabilitation devices also have a real potential to save patients money

Know More About Global Neurorehabilitation Devices - Market Report?